Li Wenda, Zhou Xue, Wu Xiang, Wei Jinxing, Huang Zejian
Department of Hepatobiliary Surgery, The Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
Cancer Manag Res. 2019 Aug 5;11:7369-7376. doi: 10.2147/CMAR.S211020. eCollection 2019.
CircRNAs involved in the development of many diseases have been recently identified. However, the possible role of circRNAs in human hepatocellular carcinoma (HCC) remains to be investigated.
This study aimed to identify the expression of hsa_circ_0085616 in different HCC cell lines and its function in HCC tumorigenesis.
The expression of hsa_circ_0085616 was first measured in 68 pairs of HCC tissues and matched normal adjacent tissues. Further analysis was performed in different HCC cell lines and human normal hepatic cell lines. Moreover, we down- or upregulated its expression by cell transfection in vitro. Cell proliferation, migration, invasion and apoptosis were measured, and proliferation-related signaling pathway proteins were also analyzed.
We found that hsa_circ_0085616 was highly expressed in all HCC cell lines compared to the normal liver cell line. Upregulation or downregulation of hsa_circ_0085616 expression could strengthen or weaken the proliferative ability of HCC cells in vitro. Moreover, the protein levels of β-catenin, p-ERK, and p-AKT, which play important roles in the typical proliferation pathway, were also affected by the expression of hsa_circ_0085616.
Our study indicated that hsa_circ_0085616 might be a potential biomarker and a new therapeutic target for HCC.
近年来,已发现环状RNA(circRNA)参与多种疾病的发展。然而,circRNA在人类肝细胞癌(HCC)中的潜在作用仍有待研究。
本研究旨在确定hsa_circ_0085616在不同肝癌细胞系中的表达及其在肝癌发生中的作用。
首先检测68对肝癌组织及其配对的癌旁正常组织中hsa_circ_0085616的表达。对不同肝癌细胞系和人正常肝细胞系进行进一步分析。此外,通过体外细胞转染上调或下调其表达。检测细胞增殖、迁移、侵袭和凋亡情况,并分析增殖相关信号通路蛋白。
我们发现,与正常肝细胞系相比,hsa_circ_0085616在所有肝癌细胞系中均高表达。上调或下调hsa_circ_0085616的表达可增强或减弱肝癌细胞的体外增殖能力。此外,在典型增殖途径中起重要作用的β-连环蛋白、磷酸化细胞外信号调节激酶(p-ERK)和磷酸化蛋白激酶B(p-AKT)的蛋白水平也受hsa_circ_0085616表达的影响。
我们的研究表明,hsa_circ_0085616可能是肝癌的潜在生物标志物和新的治疗靶点。